Ko­re­a's Cell­tri­on blue­prints $514M bi­o­log­ics plant in Chi­na, beef­ing up biosim­i­lar, con­tract man­u­fac­tur­ing

The Chi­nese city of Wuhan might have sprung to world­wide in­famy for the coro­n­avirus out­break orig­i­nat­ing from one of its seafood mar­kets, but if Cell­tri­on has its way, it will be­come known as a cen­ter of bi­o­log­ics man­u­fac­tur­ing.

The Ko­re­an biosim­i­lars mak­er has bud­get­ed $514 mil­lion (₩600 bil­lion) over five years for a new plant in Wuhan, which it says will be Chi­na’s biggest bi­o­log­ics fa­cil­i­ty at a ca­pac­i­ty of 120,000 liters. A ground­break­ing cer­e­mo­ny is slat­ed for April.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER